In this context, our data show that a large proportion of tumor-associated PD-1+ tr-NK cells coexpressed additional ICs, including those that typically inhibit NK cell function following HLA-I recognition, that is the inhibitory receptors KIRs and NKG2A. Here, KLRC1 is linked to neoplasm.